Global Airway Clearance System Market Size, Share, Forecast Report, 2020-2027
The global airway clearance system market size was valued at $652 million in 2018 and is expected to reach $922 million by 2026, registering a CAGR of 4.7% from 2019 to 2026. Airway Clearance techniques (ACTs) are treatment methods that help people suffering with disorders such as cystic fibrosis to attain a healthier lifestyle. ACTs are physical or mechanical means of simplifying the elimination of tracheobronchial phlegm through the external or internal management of air flow, and the removal of phlegm via coughing. These products loosen thick, sticky lung mucus so it can be cleared by coughing. Clearing the mucus from the airways helps in reducing lung infections and improve lung function. These airway clearance devices find their application in the treatment of various disorders including emphysema, cystic fibrosis, neuromuscular, bronchiectasis and others.
Surge in prevalence of cystic fibrosis, asthma, chronic obstructive pulmonary disease (COPD) across the world is the major factor driving the airway clearance system market growth. The major factors driving the market growth are increasing concerns of respiratory diseases, such as asthma and emphysema, and rising incidence of respiratory diseases caused due to cigarette consumption. The growth of the airway clearance system market would be boosted due to increase in healthcare expenditure, growth in the use of automation in healthcare industry, and rapid adoption of advanced medical solutions. Most of healthcare practitioners at present and pulmonary diseases specialists prefer a combination of a drug and a device, for instance inhaler and nebulizer, owing to its fast and effective outcome. However, the airway clearance system market growth could be hindered due to high cost associated with the airway clearance systems and side effects occurring due to excessive dosage, and lack of awareness regarding drug inhalation.
Global Airway Clearnce System Market Segmentation
The airway clearance system market is segmented on the basis of type, application, end user, and region. By type, it is bifurcated into positive expiratory pressure, high frequency chest wall oscillation, oscillating pep devices, intrapulmonary percussive ventilators and mechanical cough assist. Based on application, the market is segregated into emphysema, cystic fibrosis, neuromuscular bronchiectasis. By end-users it is segmented it is classified into hospital & clinics, ambulatory surgical centers, homecare settings and others Region wise, it is analyzed across North America, Europe, Asia-Pacific, and LAMEA.
Type segment review
By type, the positive expiratory pressure segment accounted for 27% of the total airway clearance system market share in 2018 and is expected to exhibit a prominent growth rate in the near future, owing to the fact that it is the most used airway clearance systems used for the treatment of cystic fibrosis. However, oscillating PEP device segment is anticipated to grow at the fastest rate during the forecast period.
Application segment review
By application, the bronchiectasis segment dominated the airway clearance system market in 2018 and is anticipated to maintain its dominance during the forecast period. This is attributed to the surge in surge in incidence of the disease across the globe. For instance, according to British Lung Foundation, around 210,000 people in the UK were living with bronchiectasis in 2016.
North America held the largest share in the airway clearance systems market in 2018, followed by Europe. The factors that drive the overall growth of the North American airway clearance systems market include significant increase in cystic fibrosis and increase in government initiates towards increasing awareness regrading COPD, asthma and other chronic respiratory disorders. In addition,presence of leading players of the airway clearance system market such as Hill Rom, Koninklijke Philips N.V., among others contributes to the market growth. Moreover, U.S. and Canada collectively accounted for around 93.8% share in 2018, with the former constituting around 75.5% share. However, Asia-Pacific is anticipated to grow at the highest rate during the analysis period. This is attributed to increase in respiratory disorder patient pool in Asia-Pacific, and significant improvement in the healthcare sector in this region. Moreover, India and China are anticipated to grow at the fastest CAGR during the forecast period, owing to the presence of highest population base; significant surge in demand for the airways clearance systems; and rise in R&D activities in the pharma and medical devices sector in the region.
Comprehensive competitive analysis and profiles of major market players such as Allergan plc, Dymedso Inc., Electromed Inc., Ltd., General Physiotherapy Inc Hill-Rom Holdings, Inc., International Biophysical Corporation, Koninklijke Philips N.V. (Philips), Monaghan Medical Corporation, Inc., and PARI GmbH, Thayer Medical. are provided in this report.
Cross-segment Market Size and Analysis for Mentioned Segments
Additional Company Profiles
(Upto 5 With No Cost)
Additional Countries (Apart
From Mentioned Countries)
Country/Region-specific Report
Go To Market Strategy
Region Specific Market DynamicsRegion Level Market Share Import Export AnalysisProduction AnalysisOthers